Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer

20260 citationsJournal Article

Authors

YUKA KIMURA · Japanese Foundation For Cancer Research

Kazuyoshi Kawakami · Japanese Foundation For Cancer Research

MASASHI NAKAMURA · Japanese Foundation For Cancer Research

Takashi Yokokawa · Tokyo University of Pharmacy and Life Sciences

Kenji Kobayashi · Japanese Foundation For Cancer Research

Takeshi Aoyama · Japanese Foundation For Cancer Research

WATARU SUZUKI

Abstract

Information on S-1 nonadherence was revealed by conducting an oncology pharmacist outpatient clinic. Improved side-effect management and medication support is expected to contribute to reducing nonadherence in the future.

Topics & Keywords

Safe Handling of Antineoplastic Drugs Gastric Cancer Management and Outcomes Medication Adherence and Compliance

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Anticancer Research

Volume 46, Issue 4, pp. 2267-2275

DOI: 10.21873/anticanres.18114

Field-Weighted Citation Impact: 0.00